News
NCI’s Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award
Two scientists at the National Cancer Institute (NCI) will receive the 2017 Lasker-DeBakey Clinical Medical Research Award for their significant research leading to the...
News
Siemens Healthineers Debuts TrueFusion Application for Treatment of Structural Heart Disease
Siemens Healthineers has introduced TrueFusion1, an application on the new Release 5.0 of the ACUSON SC2000 cardiovascular ultrasound system that integrates ultrasound and angiography...
Press Releases
Endomag Receives CE Mark Approval for Magseed Breast Cancer Localisation Technology
Endomag announced today that it has received CE Mark approval for Magseed®, a minimally invasive breast marker used to accurately guide surgeons during breast...
News
Abemaciclib Initial Therapy Improves Outcome in Endocrine-sensitive Advanced Breast Cancer
The results of the MONARCH 3 trial, presented at the ESMO 2017 Congress in Madrid (1), showed that adding the cyclin-dependent kinase (CDK) 4/6...
Research Insight
New biomarker predicts metastatic prostate cancers
Many prostate cancers, which generally are diagnosed in older men, are "indolent," slow-growing tumors that aren't destined to be fatal. But some tumors are...
Industry Reports
NuVasive announces acquisition of Vertera spine medical device company
NuVasive, Inc. , a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced the acquisition of Vertera Spine,...
Press Releases
BioPhotas Inc Clears Additional FDA and Intellectual Property Hurdles
BioPhotas, Inc. announced the FDA clearance of the Celluma, its award-winning and patented medical device, for an additional indication-for-use in treating full face wrinkles.
The FDA...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read